A Novel Mouse Model of Aortic Valve Stenosis Induced by Direct Wire Injury
暂无分享,去创建一个
Hiroki Takahashi | Isao Kubota | Takehiko Miyashita | I. Kubota | T. Arimoto | Y. Honda | T. Narumi | Tetsu Watanabe | Shinpei Kadowaki | Y. Otaki | S. Nishiyama | Hiroki Takahashi | T. Shishido | T. Miyamoto | Tetsu Watanabe | Satoshi Nishiyama | Mitsunori Ishino | Takanori Arimoto | Tetsuro Shishido | Takuya Miyamoto | T. Miyashita | Shintaro Honda | Taro Narumi | Shinpei Kadowaki | Yuki Honda | Yoichiro Otaki | Hiromasa Hasegawa | Shunsuke Netsu | Akira Funayama | M. Ishino | Hiromasa Hasegawa | Shintaro Honda | A. Funayama | Shunsuke Netsu
[1] Craig A. Simmons,et al. Animal Models of Calcific Aortic Valve Disease , 2011, International journal of inflammation.
[2] M. Schemper,et al. Statins but Not Angiotensin-Converting Enzyme Inhibitors Delay Progression of Aortic Stenosis , 2004, Circulation.
[3] M. Budoff,et al. Angiotensin-converting enzyme inhibitors and change in aortic valve calcium. , 2005, Archives of internal medicine.
[4] B. Gersh,et al. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. , 1999 .
[5] M. Thubrikar,et al. Patterns of calcific deposits in operatively excised stenotic or purely regurgitant aortic valves and their relation to mechanical stress. , 1986, The American journal of cardiology.
[6] S. Beppu,et al. Rapidity of progression of aortic stenosis in patients with congenital bicuspid aortic valves. , 1993, The American journal of cardiology.
[7] Xiaoping Yang,et al. Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: role of Smad1 and extracellular signal-regulated kinase 1/2. , 2009, The Journal of thoracic and cardiovascular surgery.
[8] I. Kubota,et al. Diacylglycerol kinase-epsilon restores cardiac dysfunction under chronic pressure overload: a new specific regulator of Galpha(q) signaling cascade. , 2008, American journal of physiology. Heart and circulatory physiology.
[9] G. Schuler,et al. Regular Exercise Training Prevents Aortic Valve Disease in Low-Density Lipoprotein–Receptor–Deficient Mice , 2010, Circulation.
[10] B. Carabello,et al. Aortic stenosis , 2018, Rapid Cardiac Care.
[11] J. Ge,et al. Relationship between aortic valve calcification and the severity of coronary atherosclerotic disease. , 2010, The Journal of heart valve disease.
[12] Ajit P Yoganathan,et al. Altered Shear Stress Stimulates Upregulation of Endothelial VCAM-1 and ICAM-1 in a BMP-4– and TGF-&bgr;1–Dependent Pathway , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[13] C. Otto,et al. Valvular aortic stenosis: disease severity and timing of intervention. , 2006, Journal of the American College of Cardiology.
[14] Bonnie K. Lind,et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. , 1997, Journal of the American College of Cardiology.
[15] T. Seidler,et al. Adenovirus-Mediated Overexpression of Diacylglycerol Kinase-&zgr; Inhibits Endothelin-1–Induced Cardiomyocyte Hypertrophy , 2005, Circulation.
[16] I. Kubota,et al. Cardiac-Specific Overexpression of Diacylglycerol Kinase &zgr; Prevents Gq Protein-Coupled Receptor Agonist-Induced Cardiac Hypertrophy in Transgenic Mice , 2005, Circulation.
[17] A. Gotlieb,et al. Advances towards understanding heart valve response to injury. , 2002, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[18] A. Mazzone,et al. Aortic valve stenosis and coronary artery disease: pathophysiological and clinical links , 2007, Journal of cardiovascular medicine.
[19] R. Weissleder,et al. In vivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation , 2011, Nature Medicine.
[20] S. Hagl,et al. Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. , 2003, Atherosclerosis.
[21] Catherine M. Otto,et al. Clinical Factors Associated With Calcific Aortic Valve Disease , 1997 .
[22] I. Kubota,et al. Diacylglycerol kinase zeta attenuates pressure overload-induced cardiac hypertrophy. , 2007, Circulation journal : official journal of the Japanese Circulation Society.
[23] Y. Deshaies,et al. A high fat/high carbohydrate diet induces aortic valve disease in C57BL/6J mice. , 2006, Journal of the American College of Cardiology.
[24] K. J. Grande,et al. Stress Variations in the Human Aortic Root and Valve: The Role of Anatomic Asymmetry , 1998, Annals of Biomedical Engineering.
[25] J. Chambers,et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. , 2008, The New England journal of medicine.
[26] I. Kubota,et al. High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. , 2008, Cardiovascular research.
[27] Rosario V. Freeman,et al. Spectrum of Calcific Aortic Valve Disease: Pathogenesis, Disease Progression, and Treatment Strategies , 2005, Circulation.
[28] Y. Bossé,et al. Genomics: the next step to elucidate the etiology of calcific aortic valve stenosis. , 2008, Journal of the American College of Cardiology.
[29] M. Yacoub,et al. In vivo aortic valve thermal heterogeneity in patients with nonrheumatic aortic valve stenosis the: first in vivo experience in humans. , 2008, Journal of the American College of Cardiology.
[30] A. Gotlieb,et al. The response to valve injury. A paradigm to understand the pathogenesis of heart valve disease. , 2011, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[31] V. Joag,et al. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. , 2007, The American journal of pathology.
[32] C. Lang,et al. Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis. , 2011, Journal of the American College of Cardiology.
[33] Yong Sun,et al. Runx2-Upregulated Receptor Activator of Nuclear Factor &kgr;B Ligand in Calcifying Smooth Muscle Cells Promotes Migration and Osteoclastic Differentiation of Macrophages , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[34] R. Brooks,et al. Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. , 2008, Journal of the American College of Cardiology.
[35] R. Levy,et al. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events. , 2007, The Annals of thoracic surgery.
[36] Ralph Weissleder,et al. Multimodality Molecular Imaging Identifies Proteolytic and Osteogenic Activities in Early Aortic Valve Disease , 2007, Circulation.
[37] R. Weiss,et al. Calcific Aortic Valve Stenosis: Methods, Models, and Mechanisms , 2011, Circulation research.
[38] Emile R. Mohler,et al. Bone Formation and Inflammation in Cardiac Valves , 2001, Circulation.
[39] R. Brooks,et al. Evidence for Active Regulation of Pro-Osteogenic Signaling in Advanced Aortic Valve Disease , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[40] S. Hagl,et al. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. , 2005, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.